The politics of valuation and payment for regenerative medicine products in the UK - HAL Accéder directement au contenu
Article dans une revue New Genetics and Society Année : 2018

The politics of valuation and payment for regenerative medicine products in the UK

Résumé

The field of regenerative medicine (RM) faces many challenges, including funding. Framing the analysis in terms of institutional politics, valuation studies and 'technologies of knowledge', the paper highlights growing debates about payment for RM in the UK, setting this alongside escalating policy debates about 'value'. We draw on interviews and publicly available material to identify the interacting and conflicting positions of institutional stakeholders. It is concluded that while there is some common ground between institutional stakeholders such as industry and health system gatekeepers, there is significant conflict about reward systems, technology assessment methodologies and payment scenarios; a range of mostly conditional payment schemes and non-mainstream routes are being experimented with. We argue that current developments highlight a fundamental conflict between a concern for the societal value of medical technologies in a resource-limited system and a concern for engineering new reward and payment models to accommodate RM innovations.
Fichier principal
Vignette du fichier
Accepted version.pdf ( 264.73 Ko ) Télécharger
Origine : Fichiers produits par l'(les) auteur(s)
Commentaires : Version pre-print
Loading...

Dates et versions

halshs-01856030, version 1 (28-11-2018)

Identifiants

Citer

Alex Faulkner, Aurélie Mahalatchimy. The politics of valuation and payment for regenerative medicine products in the UK. New Genetics and Society, 2018, ⟨10.1080/14636778.2018.1487282⟩. ⟨halshs-01856030⟩
62 Consultations
78 Téléchargements
Dernière date de mise à jour le 21/04/2024
comment ces indicateurs sont-ils produits

Altmetric

Partager

Gmail Facebook Twitter LinkedIn Plus